Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Trial of Riluzole in Patients With Resectable Stage III and IV Melanoma

NCT00667901 is registered in ClinicalTrials.gov with University of Medicine and Dentistry of New Jersey as lead sponsor.

NCT NCT00667901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Trial of Riluzole in Patients With Resectable Stage III and IV Melanoma
Lead sponsor
University of Medicine and Dentistry of New Jersey
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2007
Completion date
November 30, 2008
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)